Eli Lilly And Company Net Income per Employee (LLY), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Eli Lilly And Company  (NYSE: LLY)
 

Eli Lilly And Net Income per Employee

LLY's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 15.56% in the third quarter 2026, year on year to cumulative value of $27,580 million, and with 50,000 employees, Eli Lilly And's income per employee grew on trailing twelve month basis to $ 551,594, this marks a new company high for all of 50,000 employees.
The Healthcare sector has seen employees of 26 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 321, from total ranking in previous quarter at 461.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LLY Net Income per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Net Income Change 15.56 % 25.34 % 168.04 % 50.52 % 475.34 %
Net Income per Employee (TTM) $ 551,594 534,224 505,534 412,800 368,242
LLY's Total Ranking # 321 # 461 # 382 # 429 # 487
Seq. Net Income Change -9.08 % -4.07 % 11.42 % 18.9 % -1.38 %

LLY Company Profile >> Back to LLY Efficiency Comparisons >> Compare LLY Net Income per Employee to its Competitors

LLY Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 27
Healthcare Sector # 44
Overall Market # 321

Net Income per Employee Statistics
High Average Low
$ 551,594 $ 105,258 $ -41,438
(Sep 30 2026)   (Dec. 31, 2008)







Companies with similar Income per Employee for 12 month ending Sep 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2026Number of Employees Sep 30 2026
Nurix Therapeutics Inc   930,211.36 $ 294.877  Million 317 
Krystal Biotech Inc   763,281.36 $ 225.168  Million 295 
Illumina Inc   699,218.75 $ 895.000  Million 1,280 
Black Hawk Acquisition Corporation  649,852.50 $ 1.300  Million 2 
Eli Lilly And Company  551,594.00 $ 27,579.700  Million 50,000 
Indivior Pharmaceuticals Inc   451,000.00 $ 451.000  Million 1,000 
Denali Therapeutics Inc   393,667.99 $ 198.015  Million 503 
Neurocrine Biosciences Inc   351,250.00 $ 702.500  Million 2,000 
Standard Biotools Inc   342,097.69 $ 133.076  Million 389 
Regeneron Pharmaceuticals Inc   312,615.18 $ 4,817.400  Million 15,410 
Kiniksa Pharmaceuticals International Plc  299,366.12 $ 109.568  Million 366 
Bristol myers Squibb Company  284,338.46 $ 9,241.000  Million 32,500 


Date modified: 2026-10-30T13:15:42+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.